Product NDC: | 68084-243 |
Proprietary Name: | clindamycin hydrochloride |
Non Proprietary Name: | clindamycin hydrochloride |
Active Ingredient(s): | 150 mg/1 & nbsp; clindamycin hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 68084-243 |
Labeler Name: | American Health Packaging |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065061 |
Marketing Category: | ANDA |
Start Marketing Date: | 20080422 |
Package NDC: | 68084-243-01 |
Package Description: | 10 BLISTER PACK in 1 CARTON (68084-243-01) > 10 CAPSULE in 1 BLISTER PACK (68084-243-11) |
NDC Code | 68084-243-01 |
Proprietary Name | clindamycin hydrochloride |
Package Description | 10 BLISTER PACK in 1 CARTON (68084-243-01) > 10 CAPSULE in 1 BLISTER PACK (68084-243-11) |
Product NDC | 68084-243 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | clindamycin hydrochloride |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20080422 |
Marketing Category Name | ANDA |
Labeler Name | American Health Packaging |
Substance Name | CLINDAMYCIN HYDROCHLORIDE |
Strength Number | 150 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient] |